Related references
Note: Only part of the references are listed.RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer
Derek Dustin et al.
BRITISH JOURNAL OF CANCER (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The immunomodulatory effects of endocrine therapy in breast cancer
Huanhuan Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K. Mehta et al.
NATURE CANCER (2021)
Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects
Spencer Arnesen et al.
CANCER RESEARCH (2021)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Characterization of human cancer xenografts in humanized mice
Jonathan Rios-Doria et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Nicholas C. Turner et al.
CLINICAL CANCER RESEARCH (2020)
Innovations, challenges, and minimal information for standardization of humanized mice
Renata Stripecke et al.
EMBO MOLECULAR MEDICINE (2020)
Role of Tumor-Associated Myeloid Cells in Breast Cancer
Yoon Jin Cha et al.
CELLS (2020)
The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy
Christiana M. Neophytou et al.
FRONTIERS IN ONCOLOGY (2020)
The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models
Ilona-Petra Maser et al.
FRONTIERS IN IMMUNOLOGY (2020)
Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment
Vitaliy Davidov et al.
FRONTIERS IN IMMUNOLOGY (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
New generation breast cancer cell lines developed from patient-derived xenografts
Jessica Finlay-Schultz et al.
BREAST CANCER RESEARCH (2020)
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Xing Yi Woo et al.
CANCER RESEARCH (2020)
Enhancing tumor T cell infiltration to enable cancer immunotherapy
Jin Zhang et al.
IMMUNOTHERAPY (2019)
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A. Capasso et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER plus Breast Cancer Cells
Andres M. Castellaro et al.
CANCERS (2019)
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
Ismail M. Meraz et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Vitamin D Controls Tumor Growth and CD8+T Cell Infiltration in Breast Cancer
Esma Karkeni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting myeloid cells in the tumor sustaining microenvironment
Jonathan Schupp et al.
CELLULAR IMMUNOLOGY (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice
Satoshi Yoshihara et al.
FRONTIERS IN IMMUNOLOGY (2019)
Breast cancer genomics and immuno-oncological markers to guide immune therapies
D. Hammerl et al.
SEMINARS IN CANCER BIOLOGY (2018)
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Rinath Jeselsohn et al.
CANCER CELL (2018)
The challenges of modeling hormone receptor-positive breast cancer in mice
Berna C. Ozdemir et al.
ENDOCRINE-RELATED CANCER (2018)
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang et al.
FASEB JOURNAL (2018)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (vol 170, 1109.e1, 2017)
Antoni Ribas et al.
CELL (2018)
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
Roberto R. Rosato et al.
BREAST CANCER RESEARCH (2018)
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
A. Harrod et al.
ONCOGENE (2017)
Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts
Shawna B. Matthews et al.
HORMONES & CANCER (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Pre-metastatic niches: organ-specific homes for metastases
Hector Peinado et al.
NATURE REVIEWS CANCER (2017)
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne et al.
NATURE REVIEWS CANCER (2017)
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang et al.
CLINICAL CANCER RESEARCH (2016)
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Lacey E. Dobrolecki et al.
CANCER AND METASTASIS REVIEWS (2016)
Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do?
Ioulia Chatzistamou et al.
ENDOCRINE-RELATED CANCER (2016)
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
Sean W Fanning et al.
eLife (2016)
Estrogen receptors regulate innate immune cells and signaling pathways
Susan Kovats
CELLULAR IMMUNOLOGY (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses
Roheena Z Panni et al.
Oncotarget (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Invasive Lobular Carcinoma Cell Lines Are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen Response
Matthew J. Sikora et al.
CANCER RESEARCH (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Engineering humanized mice for improved hematopoietic reconstitution
Adam C. Drake et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice
Eva Billerbeck et al.
BLOOD (2011)
Human B Cell Development and Antibody Production in Humanized NOD/SCID/IL-2Rγnull (NSG) Mice Conditioned by Busulfan
Bongkum Choi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence
Till Strowig et al.
BLOOD (2010)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2010)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration
FE Nicolini et al.
LEUKEMIA (2004)
Share Paper
